Picture of MoonLake Immunotherapeutics logo

MLTX MoonLake Immunotherapeutics Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Annual balance sheet for MoonLake Immunotherapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
Period Length:
Source:PROSPECTUS/A10-K10-K
Standards:
USG
USG
USG
Status:FinalFinalFinal
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments8.0472.1511
Net Total Receivables1.434.183.05
Prepaid Expenses
Total Current Assets9.6476.5514
Net Property, Plant And Equipment0.0460.3323.95
Other Long Term Assets
Total Assets9.6876.8527
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities21.17.679.97
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities21.327.930.9
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity-11.648.9496
Total Liabilities & Shareholders' Equity9.6876.8527
Total Common Shares Outstanding